Association of IFNL3 Genotype with Hepatic Steatosis in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin Combination Therapy

Background: Genetic variation near the interferon lambda 3 (IFNL3) is known to be associated with response to pegylated interferon (pegIFN) and ribavirin combination therapy in patients with chronic hepatitis C virus (HCV) infection which is often accompanied by hepatic steatosis. Aims: We examined...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Int J Med Sci
Egile Nagusiak: Nakamoto, Shingo, Imazeki, Fumio, Kanda, Tatsuo, Wu, Shuang, Nakamura, Masato, Yasui, Shin, Tawada, Akinobu, Mikata, Rintaro, Chiba, Tetsuhiro, Arai, Makoto, Yokosuka, Osamu, Shirasawa, Hiroshi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2017
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666539/
https://ncbi.nlm.nih.gov/pubmed/29104462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.20171
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak